LOL!!! BioAmber is out of business, liquidated, and couldn’t fulfill their obligations under that contract if they wanted to. They never made a profit anyways, so that $14B in GUARANTEED revenue probably would have cost them $20B to deliver.
That contract was for sale with the company in the SISP. Nobody wanted it.
That contract was for sale in the liquidation. Nobody wanted it, including LCYB who could have had it with everything else.
That contract was in force the whole time the SISP and liquidation was ongoing, and if it was any sort of “gold mine,” the secured creditors would have pushed for a different outcome to the proceedings other than a liquidation and the end of business operations.
The contract ends on 12/31, BioAmber cannot deliver.
I swear I’ll never use the phrase “you can’t make this stuff up” ever again after being on the OTC because apparently you can.
